CytRx Corporation to Present at the Rodman & Renshaw Global Investment Conference
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, announces that President and CEO Steven A. Kriegsman and Vice President of Business Development David J. Haen will present at the Rodman & Renshaw Global Investment Conference on Monday, September 9, 2013, at 10:50 a.m. Eastern time (7:50 a.m. Pacific time). The conference is being held at the Millennium Broadway Hotel in New York City.
Help employers find you! Check out all the jobs and post your resume.